Citations for
1CSSSCE1, SMARCE1
Identification of a de novo splicing variant in the Coffin-Siris gene, SMARCE1, in a patient with Angelman-like syndrome.
Aguilera C, Gabau E, Laurie S, Baena N, Derdak S, Capdevila N, Ramirez A, Delgadillo V, García-Catalan MJ, Brun C, Guitart M, Ruiz A.
Mol Genet Genomic Med 7(1):e00511. doi: 10.1002/mgg3.511. Epub 2018 Dec 11. 2019
2SMARCB1, SMARCD1, SMARCE1
Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway.
He L, Chen Y, Feng J, Sun W, Li S, Ou M, Tang L.
Int J Biochem Cell Biol 90:29-37. doi: 10.1016/j.biocel.2017.07.007. Epub 2017 Jul 15. 2017
3SMARCE1
SMARCE1 is required for the invasive progression of in situ cancers.
Sokol ES, Feng YX, Jin DX, Tizabi MD, Miller DH, Cohen MA, Sanduja S, Reinhardt F, Pandey J, Superville DA, Jaenisch R, Gupta PB.
Proc Natl Acad Sci U S A 114(16):4153-4158. doi: 10.1073/pnas.1703931114. Epub 2017 Apr 4. 2017
4CSSSCE1, SMARCE1
SMARCE1, a rare cause of Coffin-Siris Syndrome: Clinical description of three additional cases.
Zarate YA, Bhoj E, Kaylor J, Li D, Tsurusaki Y, Miyake N, Matsumoto N, Phadke S, Escobar L, Irani A, Hakonarson H, Schrier Vergano SA.
Am J Med Genet A 170(8):1967-73. doi: 10.1002/ajmg.a.37722. Epub 2016 Jun 5. Review. 2016
5SMARCE1
The developmental and pathogenic roles of BAF57, a special subunit of the BAF chromatin-remodeling complex.
Lomelí H, Castillo-Robles J.
FEBS Lett 590(11):1555-69. doi: 10.1002/1873-3468.12201. Epub 2016 May 20. Review. 2016
6SMARCE1
Expression of BAF57 in ovarian cancer cells and drug sensitivity.
Yamaguchi T, Kurita T, Nishio K, Tsukada J, Hachisuga T, Morimoto Y, Iwai Y, Izumi H.
Cancer Sci 106(4):359-66. doi: 10.1111/cas.12612. Epub 2015 Feb 25. 2015
7ARID1A, CSSA1A, CSSSB1, CSSSCA2, CSSSCA4, CSSSCE1, SMARCA4, SMARCB1, SMARCE1
Genotype-phenotype correlation of Coffin-Siris syndrome caused by mutations in SMARCB1, SMARCA4, SMARCE1, and ARID1A.
Kosho T, Okamoto N; Coffin-Siris Syndrome International Collaborators.
Am J Med Genet C Semin Med Genet m J Med Genet C Semin Med Genet. 2014 Aug 28. doi: 10.1002/ajmg.c.31407. [Epub ahead of print] 2014
8SMARCE1
Aberrant BAF57 signaling facilitates prometastatic phenotypes.
Balasubramaniam S, Comstock CE, Ertel A, Jeong KW, Stallcup MR, Addya S, McCue PA, Ostrander WF Jr, Augello MA, Knudsen KE.
Clin Cancer Res 19(10):2657-67. doi: 10.1158/1078-0432.CCR-12-3049. Epub 2013 Mar 14. 2013
9SMARCE1
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.
Smith MJ, O'Sullivan J, Bhaskar SS, Hadfield KD, Poke G, Caird J, Sharif S, Eccles D, Fitzpatrick D, Rawluk D, du Plessis D, Newman WG, Evans DG.
Nat Genet 45(3):295-8. doi: 10.1038/ng.2552. Epub 2013 Feb 3. 2013
10ARID1A, ARID1B, CSS, CSSSA1A, CSSSA1B, CSSSB1, CSSSCA2, CSSSCA4, CSSSCE1, SMARCA2, SMARCA4, SMARCB1, SMARCE1
Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.
Tsurusaki Y, Okamoto N, Ohashi H, Kosho T, Imai Y, Hibi-Ko Y, Kaname T, Naritomi K, Kawame H, Wakui K, Fukushima Y, Homma T, Kato M, Hiraki Y, Yamagata T, Yano S, Mizuno S, Sakazume S, Ishii T, Nagai T, Shiina M, Ogata K, Ohta T, Niikawa N, Miyatake S, Okada I, Mizuguchi T, Doi H, Saitsu H, Miyake N, Matsumoto N.
Nat Genet at Genet. 2012 Mar 18. doi: 10.1038/ng.2219. [Epub ahead of print] 2012
11SMARCE1, TSHZ3
Teashirt-3, a novel regulator of muscle differentiation, associates with BRG1-associated factor 57 (BAF57) to inhibit myogenin gene expression.
Faralli H, Martin E, Coré N, Liu QC, Filippi P, Dilworth FJ, Caubit X, Fasano L.
J Biol Chem 286(26):23498-510. Epub 2011 May 4. 2011
12SMARCE1
A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.
Hah N, Kolkman A, Ruhl DD, Pijnappel WW, Heck AJ, Timmers HT, Kraus WL.
Cancer Res 70(11):4402-11. Epub 2010 May 11.PMID: 20460533 2010
13SMARCE1
Tau deficiency leads to the upregulation of BAF-57, a protein involved in neuron-specific gene repression.
de Barreda EG, Dawson HN, Vitek MP, Avila J.
FEBS Lett 584(11):2265-70. Epub 2010 Mar 23.PMID: 20338169 2010
14SMARCA4, SMARCB1, SMARCC1, SMARCE1
Smarcc1/Baf155 couples self-renewal gene repression with changes in chromatin structure in mouse embryonic stem cells.
Schaniel C, Ang YS, Ratnakumar K, Cormier C, James T, Bernstein E, Lemischka IR, Paddison PJ.
Stem Cells 27(12):2979-91.PMID: 19785031 2009
15SMARCE1
N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons.
Kazantseva A, Sepp M, Kazantseva J, Sadam H, Pruunsild P, Timmusk T, Neuman T, Palm K.
J Neurochem 109(3):807-18. Epub 2009 Feb 20.PMID: 19245665 2009
16SMARCE1
Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
Link KA, Balasubramaniam S, Sharma A, Comstock CE, Godoy-Tundidor S, Powers N, Cao KH, Haelens A, Claessens F, Revelo MP, Knudsen KE.
Cancer Res 68(12):4551-8.PMID: 18559499 2008
17SMARCA4, SMARCE1
Participation of Brahma-related gene 1 (BRG1)-associated factor 57 and BRG1-containing chromatin remodeling complexes in thyroid hormone-dependent gene activation during vertebrate development.
Heimeier RA, Hsia VS, Shi YB.
Mol Endocrinol 22(5):1065-77. Epub 2008 Jan 31.PMID: 18238828 2008
18SMARCE1
The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.
García-Pedrero JM, Kiskinis E, Parker MG, Belandia B.
J Biol Chem 281(32):22656-64. Epub 2006 Jun 12.PMID: 16769725 2006
19SMARCE1, AR
BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.
Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E, Weissman B, Knudsen KE.
Mol Cell Biol 25(6):2200-15. 2005
20SMARCC1, SMARCC2, SMARCE1
Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57.
Chen J, Archer TK.
Mol Cell Biol 25(20):9016-27.PMID: 16199878 2005
21NR3C1, SMARCA4, SMARCC1, SMARCC2, SMARCD1, SMARCE1
BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation.
Hsiao PW, Fryer CJ, Trotter KW, Wang W, Archer TK.
Mol Cell Biol 23(17):6210-20. 2003
22SMARCE1
Characterization of SWI/SNF protein expression in human breast cancer cell linesand other malignancies.
Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE.
J Cell Physiol 186(1):136-45. 2001
23SMARCE1
Architectural DNA binding by a high-mobility-group/kinesin-like subunit inmammalian SWI/SNF-related complexes.
Wang W, Chi T, Xue Y, Zhou S, Kuo A, Crabtree GR.
Proc Natl Acad Sci U S A 95(2):492-8. 1998
24SMARCB1, SMARCE1
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex.
Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, KalpanaGV, Goff SP, Yaniv M, Workman JL, Crabtree GR.
EMBO J 15(19):5370-82. 1996